Mirabella Financial Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,807
Closed -$643K 717
2025
Q3
$643K Buy
5,807
+1,430
+33% +$163K 0.06% 183
2025
Q2
$487K Buy
+4,377
New +$466K 0.05% 193
2024
Q1
Sell
-3,803
Closed -$308K 599
2023
Q4
$308K Buy
+3,803
New +$296K 0.04% 275
2023
Q3
Sell
-46,640
Closed -$3.59M 479
2023
Q2
$3.59M Buy
+46,640
New +$3.72M 0.39% 76
2022
Q4
Sell
-128,863
Closed -$7.95M 439
2022
Q3
$7.95M Buy
+128,863
New +$8.13M 0.83% 18
2020
Q3
Sell
-4,567
Closed -$351K 386
2020
Q2
$351K Buy
+4,567
New +$350K 0.08% 110

Other funds holding GILD

Mirabella Financial Services's GILD Position: Q4 2025 in Review

Mirabella Financial Services sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 5,807 shares — an estimated $643K sold.

Mirabella Financial Services first reported a position in GILD in Q2 2020 and held it in 6 quarters. The position peaked at $7.95M in Q3 2022. 2,220 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Mirabella Financial Services reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Mirabella Financial Services sold 5,807 Gilead Sciences shares in Q4 2025, an estimated $643K.
  • Mirabella Financial Services first reported a position in Gilead Sciences in Q2 2020 and held it in 6 quarters.
  • Mirabella Financial Services's Gilead Sciences position peaked at $7.95M in Q3 2022.
  • 2,220 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Mirabella Financial Services's 13F filing for Q4 2025, filed 17 Feb 2026.